PET Neuroimaging bei Depression

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: Gregor Gryglewski

Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien


AutorIn: o. Univ.-Prof. Dr. Dr. h. c. Siegfried Kasper

Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien


AutorIn: Assoc. Prof. PD Dr. Rupert Lanzenberger

Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien


1 Baxter L R, Jr. et al., Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46(3):243–50
2 Gryglewski G et al., Meta-analysis of molecular imaging of serotonin transporters in major depression. J Cereb Blood Flow Metab 2014; 34(7):1096–103
3 Lanzenberger R et al., Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas. Neuroimage 2012; 63(2):874–81
4 Hahn A et al., Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression. Hum Brain Mapp 2014; 35(8):3857–66
5 Murrough J W et al., Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology (Berl) 2011; 213(2–3):547–53
6 Cannon DM et al., Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology 2009; 34(5):1277–87
7 Attar-Levy D et al., The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry 1999; 45(2):180–6
8 Savitz JB, Drevets WC, Neuroreceptor imaging in depression. Neurobiol Dis 2013; 52:49–65
9 Meyer JH et al., Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Arch Gen Psychiatry 2009; 66(12):1304–12
10 Dewar KM et al., [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Synapse 1991; 9(1):14–26
11 Whitworth TL et al., Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons. J Neurosci 2002; 22(1):RC192
12 Savli M et al., Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage 2012; 63(1):447–59
13 Saulin A et al., Serotonin and molecular neuroimaging in humans using PET. Amino Acids (2012); 42(6):2039–57
14 Baldinger P et al., Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET. Neuroimage 2014; 88:252–62
15 Sheline YI et al., Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001; 50(9):651–8
16 Nord M et al., Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain. Int J Neuropsychopharmacol 2013; 16(7):1577–86
17 Meyer JH et al., Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry 2004; 161(5):826–35
18 Kasper S et al., Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. Int Clin Psychopharmacol 2009; 24(3):119–25
19 Sibon I et al., Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biol Psychiatry 2008; 63(12):1135–40
20 Moses-Kolko EL et al., Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse 2007; 61(7):523–30
21 Lanzenberger R et al., Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol Psychiatry 2013; 18(1):93–100
22 Tiger M et al., Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Res 2014; 223(2):164–70

SP 04|2014

Herausgeber: Univ.-Prof. Dr. Michael Musalek
Publikationsdatum: 2014-12-22